EFFICIENCY OF THE VINORELBINE – CAPECITABINE + BEVASIZUMAB REGIMEN IN THE TREATMENT OF PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER. Web med. 2024;2(11):91-97. Accessed October 3, 2025. https://webofjournals.com/index.php/5/article/view/2184